A dual NK1 and NK3 receptor antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Elinzanetant

Item No. 43016

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
N-[4-(4-fluoro-2-methylphenyl)-6-[(7S,9aS)-hexahydro-7-(hydroxymethyl)pyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-3-pyridinyl]-N,α,α-trimethyl-3,5-bis(trifluoromethyl)-benzeneacetamide
CAS Number
929046-33-3
Synonyms
  • BAY-3427080
  • GSK1144814
  • NT-814
Molecular Formula
C33H35F7N4O3
Formula Weight
668.7
Purity
≥98%
Formulation
A solid
Solubility(Learn about Variance in Solubility)
DMSO: Soluble: ≥10 mg/mlEthanol: Soluble: ≥10 mg/ml
SMILES
OC[C@H](CN1[C@@](COCC1)([H])C2)N2C3=NC=C(N(C(C(C)(C)C4=CC(C(F)(F)F)=CC(C(F)(F)F)=C4)=O)C)C(C5=C(C)C=C(F)C=C5)=C3
InChi Code
InChI=1S/C33H35F7N4O3/c1-19-9-23(34)5-6-26(19)27-13-29(44-16-25-18-47-8-7-43(25)15-24(44)17-45)41-14-28(27)42(4)30(46)31(2,3)20-10-21(32(35,36)37)12-22(11-20)33(38,39)40/h5-6,9-14,24-25,45H,7-8,15-18H2,1-4H3/t24-,25-/m0/s1
InChi Key
DWRIJNIPBUFCQS-DQEYMECFSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    5 mg

    $297

    Add

    10 mg

    $476

    Add

    25 mg

    $818

    Add

    50 mg

    $1,188

    Add
    Product Description

    Elinzanetant is a dual neurokinin-1 (NK1) and NK3 receptor antagonist.1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Hager, M., Goldstein, T., Fitz, V., et al. Elinzanetant, a new combined neurokinin-1/-3 receptor antagonist for the treatment of postmenopausal vasomotor symptoms. Expert Opin. Pharmacother. 25(7), 783-789 (2024).